• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[儿童发热性中性粒细胞减少癌症患者的菌血症风险标准]

[Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient].

作者信息

Gala Peralta Sandra, Cardesa Salzman Teresa, García García Juan José, Estella Aguado Jesús, Gené Giralt Amadeu, Luaces Cubells Carles

机构信息

Sección de Urgencias, Servicio de Pediatría, Hospital Sant Joan de Déu, Barcelona, España.

出版信息

Clin Transl Oncol. 2005 May;7(4):165-8. doi: 10.1007/BF02708754.

DOI:10.1007/BF02708754
PMID:15960924
Abstract

INTRODUCTION

Cancer patients with febrile neutropenia are not a homogeneous group with respect to risk of bacterial infections. Some authors have proposed that febrile cancer patients with low risk factors of bacteraemia could be managed at home with domiciliary antibiotic treatment. The objectives are: to determine the incidence of bacteraemia in our cancer patients who have febrile neutropenia; and to identify the low-risk factors so that the patients can be managed at home using domiciliary antibiotic treatment.

MATERIAL AND METHODS

Clinical review of paediatric haemato-oncology disease admitted to our hospital in 2002 suffering from febrile neutropenia.

RESULTS

We describe a total of 62 episodes of febrile neutropenia in 30 patients; 24 episodes in haematology patients and 38 episodes in oncology patients. High-risk criteria are age <1 year, poor bone-marrow recovery, chemotherapy within 10 days of the episode, rapid fast neutropenia, leukaemia in relapse, uncontrolled solid cancer, and cardiac or nephrology disease. Based on the number of risk-factors, patients with two or less risk-factors have an incidence of bacteraemia of 6.7% (1/16) and patients with three or more risk factors have an incidence of bacteraemia of 32.6% (15/46); p<0.05.

CONCLUSIONS

Incidence of bacteraemia is similar to the reviewed literature; probability of bacteraemia increases with the number of individual risk factors, and patients with low risk of bacteraemia could be managed on an outpatient basis using domiciliary antibiotic treatment.

摘要

引言

发热性中性粒细胞减少症的癌症患者在细菌感染风险方面并非同质化群体。一些作者提出,菌血症风险低的发热癌症患者可在家接受家庭抗生素治疗。目标是:确定我院发热性中性粒细胞减少症癌症患者的菌血症发生率;并识别低风险因素,以便患者能在家接受家庭抗生素治疗。

材料与方法

对2002年我院收治的患有发热性中性粒细胞减少症的儿科血液肿瘤疾病进行临床回顾。

结果

我们共描述了30例患者的62次发热性中性粒细胞减少症发作;血液学患者24次发作,肿瘤学患者38次发作。高风险标准为年龄<1岁、骨髓恢复差、发作10天内进行化疗、快速出现重度中性粒细胞减少、白血病复发、实体癌未控制以及心脏或肾脏疾病。根据风险因素数量,风险因素为两个或更少的患者菌血症发生率为6.7%(1/16),风险因素为三个或更多的患者菌血症发生率为32.6%(15/46);p<0.05。

结论

菌血症发生率与文献综述相似;菌血症的可能性随个体风险因素数量增加而增加,菌血症风险低的患者可门诊接受家庭抗生素治疗。

相似文献

1
[Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient].[儿童发热性中性粒细胞减少癌症患者的菌血症风险标准]
Clin Transl Oncol. 2005 May;7(4):165-8. doi: 10.1007/BF02708754.
2
A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).儿童与成人发热性中性粒细胞减少症发作的结局比较:四项欧洲癌症研究与治疗组织(EORTC)研究的结果。欧洲癌症研究与治疗组织(EORTC)国际抗菌治疗合作组(IATCG)
Br J Haematol. 1997 Dec;99(3):580-8. doi: 10.1046/j.1365-2141.1997.4453255.x.
3
Low-risk febrile neutropenia in a medical oncology unit.肿瘤内科病房的低风险发热性中性粒细胞减少症
Aust N Z J Med. 1997 Aug;27(4):403-7. doi: 10.1111/j.1445-5994.1997.tb02199.x.
4
Bacteraemia in febrile neutropenic cancer patients.发热性中性粒细胞减少症癌症患者的菌血症
Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S51-9. doi: 10.1016/j.ijantimicag.2007.06.012. Epub 2007 Aug 8.
5
Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors.
Eur J Cancer. 2003 Jun;39(9):1284-9. doi: 10.1016/s0959-8049(03)00272-7.
6
Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients.发热性儿科癌症患者中性粒细胞减少与留置中心静脉导管相关菌血症发生率之间无关联。
Pediatr Infect Dis J. 1991 Jul;10(7):506-10. doi: 10.1097/00006454-199107000-00005.
7
The outcome of febrile neutropenic episodes in paediatric oncology at the Wendy Fitzwilliam Paediatric Hospital.温迪·菲茨威廉儿童医院儿科肿瘤患者发热性中性粒细胞减少症发作的结果。
West Indian Med J. 2011 Mar;60(2):153-7.
8
Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.儿科发热性中性粒细胞减少肿瘤患者血行感染病原菌的微生物谱及药敏模式:采用不同抗生素治疗方案的两个连续时间段的比较
Int J Antimicrob Agents. 2005 Jun;25(6):469-73. doi: 10.1016/j.ijantimicag.2005.01.020.
9
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.黎巴嫩发热性中性粒细胞减少成年癌症患者中引起菌血症的第三代头孢菌素耐药肠杆菌科细菌和多重耐药革兰氏阴性菌、作为主要危险因素的广谱抗生素使用以及与预后不良的相关性
Front Cell Infect Microbiol. 2015 Feb 12;5:11. doi: 10.3389/fcimb.2015.00011. eCollection 2015.
10
Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.恶性肿瘤患儿发热性中性粒细胞减少症发作时菌血症的风险指数评分
J BUON. 2009 Jul-Sep;14(3):411-8.

引用本文的文献

1
Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study.西班牙三级护理医院肿瘤患者发热性中性粒细胞减少症的流行病学及特征:PINNACLE研究
Mol Clin Oncol. 2015 May;3(3):725-729. doi: 10.3892/mco.2015.524. Epub 2015 Mar 5.
2
Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.系统评价和荟萃分析:儿童和青少年发热性中性粒细胞减少症风险预测规则的鉴别性能。
Eur J Cancer. 2010 Nov;46(16):2950-64. doi: 10.1016/j.ejca.2010.05.024.

本文引用的文献

1
[Meropenem therapy in children with febrile neutropenia].[美罗培南治疗儿童发热性中性粒细胞减少症]
Orv Hetil. 2003 Oct 26;144(43):2115-20.
2
Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.识别化疗引起的中性粒细胞减少症伴发热且严重细菌感染低风险的儿童。
Med Pediatr Oncol. 2003 Nov;41(5):436-43. doi: 10.1002/mpo.10320.
3
Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.早期淋巴细胞减少作为化疗引起的发热性中性粒细胞减少的一个危险因素。
Am J Hematol. 2003 Aug;73(4):263-6. doi: 10.1002/ajh.10363.
4
Outpatient management of febrile neutropenia in children with cancer.癌症患儿发热性中性粒细胞减少症的门诊管理
Paediatr Drugs. 2003;5(7):443-55. doi: 10.2165/00128072-200305070-00002.
5
Evolving concepts of management of febrile neutropenia in children with cancer.癌症患儿发热性中性粒细胞减少症管理理念的演变
Med Pediatr Oncol. 2002 Aug;39(2):77-85. doi: 10.1002/mpo.10073.
6
Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer.癌症患儿发热性中性粒细胞减少发作风险预测标准的评估。
J Pediatr Hematol Oncol. 2002 Jan;24(1):38-42. doi: 10.1097/00043426-200201000-00011.
7
Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.1100例发热性中性粒细胞减少症儿科肿瘤患者中与低菌血症风险相关的临床参数。
Cancer. 2001 Aug 15;92(4):909-13. doi: 10.1002/1097-0142(20010815)92:4<909::aid-cncr1400>3.0.co;2-h.
8
Trends in infection morbidity in a pediatric oncology ward, 1986-1995.
Med Pediatr Oncol. 1999 May;32(5):336-43. doi: 10.1002/(sici)1096-911x(199905)32:5<336::aid-mpo5>3.0.co;2-4.
9
Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia.头孢曲松单药治疗低风险发热性中性粒细胞减少症。
Chemotherapy. 1998 Sep-Oct;44(5):343-54. doi: 10.1159/000007134.
10
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.一项针对菌血症低风险的发热性中性粒细胞减少症癌症患儿门诊管理的试点研究。
J Pediatr. 1996 Jun;128(6):847-9. doi: 10.1016/s0022-3476(96)70339-6.